| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/26/2004 | US20040037833 Comprises purified imunoglobulin polypeptide or antigen binding fragment for diagnosis of disease/cancer |
| 02/26/2004 | US20040037829 For immunoregulation and/or treatment of inflammation; muteins |
| 02/26/2004 | US20040037828 Methods and pharmaceutical compositions for healing wounds |
| 02/26/2004 | US20040037823 Epidermal growth factors (ErbB2); comprises doxorubicin; gene expression inhibition; anticancer agents |
| 02/26/2004 | US20040037821 For expression of erythropoietin; genetic translocation; zinc finger motifs |
| 02/26/2004 | US20040037819 Non-polymeric hematopoeitic cell clots for delivery of active agents |
| 02/26/2004 | US20040037815 Isolation and use of solid tumor stem cells |
| 02/26/2004 | US20040037814 Comprises immature animal cells characterized by expression of alpha-fetoprotein and albumin; extracelluar matrix is formed from collagen, fibronectin, and laminin; solid phase synthesis; for liver transplants |
| 02/26/2004 | US20040037780 Delivery of an exogenous gene to the respiratory epithelium in a lentiviral expression vector. Includes the preconditioning of the respiratory tract with a penetrating agent such as a detergent to cause tolerable transient damage |
| 02/26/2004 | US20040037744 Arrays formed of encoded beads having ligands attached |
| 02/26/2004 | US20040035794 Microchip electrospray device and column with affinity adsorbents and use of the same |
| 02/26/2004 | US20040035793 For enhancing sensitivity of mutation detection by denaturing high performance liquid chromatography |
| 02/26/2004 | US20040035787 Particulate support for separation/purification or extraction and process of producing the same |
| 02/26/2004 | DE10238979A1 Preparing zeaxanthin and its precursors or products, useful as food and feed supplements, comprises growing transgenic plants that have reduced epsilon-cyclase activity |
| 02/26/2004 | DE10237517A1 Removing biomolecules from liquid media, useful for purification, product recovery or preparation of vectors, comprises retention on hydrotalcite of controlled porosity |
| 02/26/2004 | DE10233047A1 Preparing synthetic polypeptides, particularly fluorescent proteins, useful in pharmaceutical compositions, by aligning sequences of known proteins to define an average sequence |
| 02/26/2004 | DE10225139A1 Verfahren zur Identifizierung von immunreaktiven Peptiden A method for identifying immunoreactive peptides |
| 02/26/2004 | CA2535760A1 Apicomplexan pathways, inhibitiors, and drug delivery |
| 02/26/2004 | CA2535748A1 Pthrp-derived modulators of smooth muscle proliferation |
| 02/26/2004 | CA2507486A1 .alpha.(1,3)-galactosyltransferase null cells, methods of selecting and .alpha.(1,3)-galactosyltransferase null swine produced therefrom |
| 02/26/2004 | CA2497304A1 Bmp-2 estrogen responsive element and methods of using the same |
| 02/26/2004 | CA2496437A1 Improved methods of in vitro protein synthesis |
| 02/26/2004 | CA2496419A1 Antibodies directed to monocyte chemo-attractant protein-1 (mcp-1) and uses thereof |
| 02/26/2004 | CA2496141A1 Methods and reagents for surface functionalization |
| 02/26/2004 | CA2496048A1 Use of murine genomic regions identified to be involved in tumor development for the development of anti-cancer drugs and diagnosis of cancer |
| 02/26/2004 | CA2496029A1 Carbohydrate library constructed by gene alteration of cargo receptors |
| 02/26/2004 | CA2495730A1 Avian sex determination method |
| 02/26/2004 | CA2495727A1 Nonhuman model animal nonresponsive to endotoxin and lipoprotein or lipopeptide |
| 02/26/2004 | CA2495664A1 Novel variant hyprocrea jecorina cbh1 cellulases |
| 02/26/2004 | CA2495411A1 Real time measurement of cellular responses |
| 02/26/2004 | CA2495398A1 Antisense modulation of nav1.3 expression |
| 02/26/2004 | CA2495391A1 Assaying compounds or agents for microsomal prostaglandin e synthase or hematopoietic prostaglandin d synthase activity |
| 02/26/2004 | CA2495185A1 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
| 02/26/2004 | CA2495177A1 Novel n-acetylgalactosamine transferases and nucleic acids encoding the same |
| 02/26/2004 | CA2495037A1 Antisense modulation of acyl-coa synthetase 1 expression |
| 02/26/2004 | CA2494986A1 Method of plastid transformation in lettuce |
| 02/26/2004 | CA2494971A1 Heteropolymeric compound comprising a scaffold, an adjuvant and an antigen, and its use |
| 02/26/2004 | CA2494887A1 Modified tailed oligonucleotides |
| 02/26/2004 | CA2494847A1 Enos mutants useful for gene therapy |
| 02/26/2004 | CA2494845A1 Gene therapy for critical limb ischemia with wild type or mutant enos |
| 02/26/2004 | CA2494841A1 Bacterial effector proteins which inhibit programmed cell death |
| 02/26/2004 | CA2493822A1 Methods and compositions for targeting secretory lysosomes |
| 02/26/2004 | CA2493753A1 Immunostimulatory nucleic acids |
| 02/26/2004 | CA2492932A1 Methods for inducing targeted stimulation of meiotic recombination and kits for performing said methods |
| 02/26/2004 | CA2492927A1 Method of expressing gene in transgenic birds using retrovirus vector and transgenic birds thus obtained |
| 02/26/2004 | CA2492524A1 Humanized rabbit antibodies |
| 02/26/2004 | CA2492167A1 Wheat plants having increased resistance to imidazolinone herbicides |
| 02/25/2004 | EP1391520A1 Method for preservation of cells and nucleic acid targets |
| 02/25/2004 | EP1391518A1 Process for producing peptide |
| 02/25/2004 | EP1391516A1 Von willebrand factor (vwf)-cleaving enzyme |
| 02/25/2004 | EP1391515A1 Process for producing coenzyme q 10 |
| 02/25/2004 | EP1391514A1 Pharmaceutical composition for treatment of angiogenesis-dependent conditions |
| 02/25/2004 | EP1391513A1 IL-7 drug substance, IL-7 comprising composition, preparation and uses thereof |
| 02/25/2004 | EP1391512A1 Polypeptide serving as angiogenic marker and dna thereof |
| 02/25/2004 | EP1391511A1 Artificial human chromosome containing human antibody lambda light chain gene |
| 02/25/2004 | EP1391510A1 Method of constructing host and process for producing foreign protein |
| 02/25/2004 | EP1391509A1 Transformed silkworm producing human collagen |
| 02/25/2004 | EP1391508A1 Transgenic nematode expressing mammalian GPCRS used for screening assay |
| 02/25/2004 | EP1391506A1 Animal with gene hypoexpression |
| 02/25/2004 | EP1391464A1 Anti-cd40 monoclonal antibody |
| 02/25/2004 | EP1391241A1 The use of microfluidic systems in the electrochemical detection of target analytes |
| 02/25/2004 | EP1390758A2 Method of identifying modulators of nogo-functions |
| 02/25/2004 | EP1390744A2 Isolation and identification of mouse and human transcription control elements associated with cytochrome expression |
| 02/25/2004 | EP1390710A2 Amplification and detection of $i(mycoplasma pneumoniae) |
| 02/25/2004 | EP1390548A2 Cells for detection of enteroviruses |
| 02/25/2004 | EP1390547A1 Antisense modulation of interleukin 12 p35 subunit expression |
| 02/25/2004 | EP1390546A2 Biological sample processing methods and compositions that include surfactants |
| 02/25/2004 | EP1390545A1 Biological sample processing methods and compositions that include surfactants |
| 02/25/2004 | EP1390544A2 Universal multi-variant detection system |
| 02/25/2004 | EP1390543A2 New polynucleotides and polypeptides of the ifnalpha-17 gene |
| 02/25/2004 | EP1390542A2 Nucleic acid detection method |
| 02/25/2004 | EP1390541A2 Method for detecting gram-positive bacteria |
| 02/25/2004 | EP1390540A1 Chemically assembled nano-scale circuit elements |
| 02/25/2004 | EP1390538A2 Detection of microsatellite instability and its use in diagnosis of tumors |
| 02/25/2004 | EP1390537A2 Methods and compositions for amplification of rna sequences |
| 02/25/2004 | EP1390536A1 Antisense modulation of tumor necrosis factor receptor 2 expression |
| 02/25/2004 | EP1390535A2 Combinatorial libraries of monomer domains |
| 02/25/2004 | EP1390534A2 Methods for diagnosis and treatment of inflammatory bowel disease |
| 02/25/2004 | EP1390533A2 Analytical method and kit |
| 02/25/2004 | EP1390532A2 Amplification process |
| 02/25/2004 | EP1390531A2 Quantitative diagnostic analysis of hypertonia |
| 02/25/2004 | EP1390530A2 Method for relative quantification of attached nucleic acids |
| 02/25/2004 | EP1390528A2 Gene markers useful for detecting skin damage in response to ultraviolet radiation |
| 02/25/2004 | EP1390522A1 Acetate-free purification of plasmid dna on hydroxyapatite |
| 02/25/2004 | EP1390519A2 Microorganisms and processes for enhanced production of pantothenate |
| 02/25/2004 | EP1390518A2 Buffer solution for electroporation and a method comprising the use of the same |
| 02/25/2004 | EP1390517A2 Replicons derived from positive strand rna virus genomes useful for the production of heterologous proteins |
| 02/25/2004 | EP1390516A1 Novel expression vectors and uses thereof |
| 02/25/2004 | EP1390515A2 Compositions and methods of increasing stress tolerance in plants |
| 02/25/2004 | EP1390514A2 Regulatory protein involved in pectin modification |
| 02/25/2004 | EP1390513A1 Double selection cloning method and vectors therefor |
| 02/25/2004 | EP1390512A1 A method for transfection of rna using electrical pulses |
| 02/25/2004 | EP1390511A2 Enhanced production of recombinant proteins by transient transfection of suspension-growing mammalian cells |
| 02/25/2004 | EP1390510A1 Crystal structure of ketopantoate reductase and use thereof |
| 02/25/2004 | EP1390509A2 Sequence of the tropheryma whippelii bacteria rpob gene and oligonucleotide for molecular diagnosis of whipple's disease |
| 02/25/2004 | EP1390508A2 A retinoic acid metabolizing cytochrome p450 |
| 02/25/2004 | EP1390507A2 Genes and proteins involved in the biosynthesis of enediyne ring structures |
| 02/25/2004 | EP1390506A1 A variable region of the monoclonal antibody against the hbv s-surface antigen and a gene encoding the same |
| 02/25/2004 | EP1390505A2 Antigens of group b streptococcus and corresponding dna fragments |
| 02/25/2004 | EP1390504A2 Nucleotide sequences which code for the metd gene |